Megan McNerney

University of Chicago

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (5)

Sandeep Gurbuxani

Associate Professor

University of Chicago

UNITED STATES

View details

Yasmin Karimi

University of Michigan

UNITED STATES

View details

Jeremy Baeten

Assistant Professor

Washington University in St. Louis

UNITED STATES

View details

James Allan

Professor of Cancer Genetics

Newcastle University

UNITED KINGDOM

View details

Stephen Kron

Professor

University of Chicago

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Megan McNerney

Research Interests

Explore related searches

Contact this professor

Articles (11)

CUX1 regulates human hematopoietic stem cell chromatin accessibility via the BAF complex

Oncogenic RAS promotes leukemic transformation of CUX1-deficient cells

Inherited cancer predisposing mutations in patients with therapy‐related myeloid neoplasms

Genomic studies controvert the existence of the CUX1 p75 isoform

EGR1 Haploinsufficiency Confers a Fitness Advantage to Hematopoietic Stem Cells Following Chemotherapy

CRISPR screening in human hematopoietic stem and progenitor cells reveals an enrichment for tumor suppressor genes within chromosome 7 commonly deleted regions

The significance of CUX1 and chromosome 7 in myeloid malignancies.

Loss of a 7q gene, CUX1, disrupts epigenetically driven DNA repair and drives therapy-related myeloid neoplasms

Venetoclax imparts distinct cell death sensitivity and adaptivity patterns in T cells

Cytotoxic Therapy-Induced Effects on Both Hematopoietic and Marrow Stromal Cells Promotes Therapy-Related Myeloid Neoplasms.

A phase 1 study of azacitidine with high-dose cytarabine and mitoxantrone in high-risk acute myeloid leukemia.

Collaborators (5)

Sandeep Gurbuxani

Yasmin Karimi

Jeremy Baeten

James Allan

Stephen Kron

Make your next move.